KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Consolidated Net Income (2016 - 2025)

Sarepta Therapeutics has reported Consolidated Net Income over the past 15 years, most recently at $352.8 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at $352.8 million for Q4 2025, up 122.23% from a year ago — trailing twelve months through Dec 2025 was -$77.7 million (down 133.07% YoY), and the annual figure for FY2025 was -$77.7 million, down 133.07%.
  • Consolidated Net Income for Q4 2025 was $352.8 million at Sarepta Therapeutics, up from -$179.9 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for SRPT hit a ceiling of $352.8 million in Q4 2025 and a floor of -$516.7 million in Q1 2023.
  • Median Consolidated Net Income over the past 5 years was -$32.4 million (2023), compared with a mean of -$29.8 million.
  • Peak annual rise in Consolidated Net Income hit 2940.57% in 2025, while the deepest fall reached 1338.98% in 2025.
  • Sarepta Therapeutics' Consolidated Net Income stood at $249.3 million in 2021, then crashed by 42.99% to $142.1 million in 2022, then skyrocketed by 130.0% to $326.9 million in 2023, then plummeted by 51.44% to $158.8 million in 2024, then surged by 122.23% to $352.8 million in 2025.
  • The last three reported values for Consolidated Net Income were $352.8 million (Q4 2025), -$179.9 million (Q3 2025), and $196.9 million (Q2 2025) per Business Quant data.